PAOG Expects To Soon Launch 3rd CBD Nutraceutical Adding To
Sandusky, OH, Nov. 09, 2021 (Globalrelease Wire) — PAO Group, Inc. (OTC Pink: PAOG) today announced the company is on track to introduce yet a third CBD nutraceutical product by …
Ocugen Inc. Announces Inducement Grants Under Nasdaq
MALVERN, Pa., Oct. 16, 2021 (Globalrelease Wire) — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine …
Adverum Presents Clinical Data on ADVM-022 at the American
REDWOOD CITY, Calif., Oct. 09, 2021 (Globalrelease Wire) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today is …
Shattuck Labs to Present Clinical Data on SL-172154 and
AUSTIN, TX and DURHAM, NC, Oct. 01, 2021 (Globalrelease Wire) — Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a …
MacroGenics Announces Presentations at ESMO 2021 Virtual
ROCKVILLE, MD, Sept. 12, 2021 (Globalrelease Wire) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today …
ProQR Announces Virtual Presentation at EURETINA 2021
LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 06, 2021 (Globalrelease Wire) — ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA therapies for genetic eye …
XcelPlus International appoints new CEO and Board of
RENO, NV, Sept. 01, 2021 (Globalrelease Wire) — XcelPlus International Inc. (OTC Pink: XLPID) announced today a strategic reshuffling of its management team, including the appointment of energy industry veteran …
atai Life Sciences to Present at the 41st Annual Canaccord
BERLIN, Aug. 06, 2021 (Globalrelease Wire) — atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, today announced that …
Madrigal Pharmaceuticals Offers Patients Resmetirom in a
CONSHOHOCKEN, Pa., July 13, 2021 (Globalrelease Wire) — Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) announced today its first patient dosed in a planned 52-week open label active treatment extension study of MAESTRO-NAFLD-1, …
Sana Biotechnology Presents Data at ISSCR 2021 Virtual
First demonstration of the survival of allogeneic iPSCs transplanted into an immunocompetent non-human primate model without the need for immune suppression Transplanting allogeneic cells into a primate without immune suppression …